deltatrials
Unknown PHASE3 INTERVENTIONAL 3-arm NCT02363517

The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach (TAP)

The Treatment And Prevention (TAP) Study: Treating People Who Inject Drugs (PWID) in Community-based Settings Using a Social Network Approach

Sponsor: Macfarlane Burnet Institute for Medical Research and Public Health Ltd

Conditions Drug Abuse, Intravenous Hepatitis C
Interventions Sofosbuvir/ledispasvir fixed dose combination (SOF + LDP)
Updated 7 times since 2017 Last updated: Apr 8, 2018 Started: Feb 28, 2015 Primary completion: Dec 31, 2018 Completion: Dec 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Drug Abuse, Intravenous and Hepatitis C and is currently ongoing. Macfarlane Burnet Institute for Medical Research and Public Health Ltd leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshotRecruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotRecruiting~Jun 2018 – ~May 2020 · 23 months · monthly snapshotRecruiting~May 2020 – ~Jan 2021 · 8 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. May 2020 — Jan 2021 [monthly]

    Unknown Status PHASE3

    Status: Recruiting → Unknown Status

  5. Jun 2018 — May 2020 [monthly]

    Recruiting PHASE3

▶ Show 2 earlier versions

  1. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

  2. Jan 2017 — Oct 2017 [monthly]

    Recruiting PHASE3

    First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Macfarlane Burnet Institute for Medical Research and Public Health Ltd
  • St Vincent's Hospital Melbourne
Data source: Macfarlane Burnet Institute for Medical Research and Public Health Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations